Social prescribing for primary care in the UK: costs and health benefits are uncertain
Citation: Bickerdike L, Booth A, Wilson PM, et al. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open 2017; 7: e013384
What is this? The COVID-19 pandemic is placing a strain on health systems and healthcare workers. Existing research on social prescribing, which links patients in primary care to sources of support within the community, may provide information to ease this.
In this systematic review, the authors searched for research evaluating any form of social prescribing programmes that had been conducted in the UK. They restricted the search to publications in English between 2000 and January 2016 and did the searches in February 2016. They included 1 randomised trial, 1 non-randomised trial, two qualitative studies, 4 uncontrolled before-and-after studies and 8 descriptive reports.
What was found: Patient experience reports were generally positive about social prescribing in the UK, but the effects are not quantifiable.
Although there may be a reduction in primary care and secondary care contacts, the extent of this, and the costs and health effects of social prescribing are uncertain.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.